SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-088678
Filing Date
2022-03-30
Accepted
2022-03-30 07:52:37
Documents
16
Period of Report
2022-03-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d329199d8k.htm   iXBRL 8-K 25377
2 EX-99.1 d329199dex991.htm EX-99.1 73109
8 GRAPHIC g329199dsp01.jpg GRAPHIC 4137
  Complete submission text file 0001193125-22-088678.txt   249925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atai-20220330.xsd EX-101.SCH 4714
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atai-20220330_cal.xml EX-101.CAL 714
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atai-20220330_def.xml EX-101.DEF 1719
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20220330_lab.xml EX-101.LAB 18691
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20220330_pre.xml EX-101.PRE 11487
10 EXTRACTED XBRL INSTANCE DOCUMENT d329199d8k_htm.xml XML 3190
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 22783188
SIC: 2834 Pharmaceutical Preparations